Hughes Financial Services’s Soleno Therapeutics SLNO Stock Holding History

Hughes Financial Services’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$33	–	1930
2026 Q1	$33	Sell	1 -2	-67%	-$78	﹤0.01%	1541
2025 Q4	$139	Buy	+3	New	+$164	﹤0.01%	1028

Hughes Financial Services's SLNO Position: Q2 2026 in Review

Hughes Financial Services sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 1 share — an estimated $33 sold.

Hughes Financial Services first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $139 in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Hughes Financial Services reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Hughes Financial Services sold 1 Soleno Therapeutics share in Q2 2026, an estimated $33.
Hughes Financial Services first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
Hughes Financial Services's Soleno Therapeutics position peaked at $139 in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.